Home › Funds › HEARTLAND ADVISORS INC › XRAY
HEARTLAND ADVISORS INC position in XRAY
DENTSPLY SIRONA INC · Health Care
HEARTLAND ADVISORS INC reported holding 1,591,750 shares of XRAY (DENTSPLY SIRONA INC) in its Q3 2026 13F filing — a position valued at US$14.1M, representing 0.68% of its reported portfolio and ranking #38 among its reported holdings. HEARTLAND ADVISORS INC has disclosed XRAY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How HEARTLAND ADVISORS INC's XRAY position evolved
HEARTLAND ADVISORS INC first disclosed a stake in XRAY in Q3 2023 at 255,724 shares (US$8.7M). The position peaked in Q2 2025 at 1,526,333 shares, worth US$24.2M. Across 13 filings, HEARTLAND ADVISORS INC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,591,750 shares valued at US$14.1M — an increase of 424,400 shares quarter over quarter.. Notable position changes include a 95% increase in Q1 2024 (shares fell 25% over the following quarter), a 94% increase in Q3 2024 (shares fell 30% over the following quarter), a 491% increase in Q1 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 255.72K | $8.74M | New |
| Q4 2023 | 198.44K | $7.06M | Reduce |
| Q1 2024 | 386.52K | $12.83M | Add |
| Q2 2024 | 284.16K | $7.08M | Reduce |
| Q3 2024 | 550.75K | $14.90M | Add |
| Q4 2024 | 712.40K | $13.52M | Add |
| Q1 2025 | 933.85K | $13.95M | Add |
| Q2 2025 | 1.53M | $24.24M | Add |
| Q3 2025 | 1.31M | $16.65M | Reduce |
| Q4 2025 | 161.40K | $1.84M | Reduce |
| Q1 2026 | 953.25K | $11.06M | Add |
| Q2 2026 | 1.17M | $12.39M | Add |
| Q3 2026 | 1.59M | $14.10M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About XRAY and 13F data
XRAY (DENTSPLY SIRONA INC) is a Health Care company. 12 other funds we track also report a position in XRAY — the largest reported positions include ARIEL INVESTMENTS, LLC (US$77.0M), Southpoint Capital Advisors LP (US$74.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding XRAY
- ARIEL INVESTMENTS, LLC 8.69M sh · $77.00M · Q3 2026
- Southpoint Capital Advisors LP 7.00M sh · $74.27M · Q2 2026
More on HEARTLAND ADVISORS INC
FAQ
How long has HEARTLAND ADVISORS INC held XRAY?
HEARTLAND ADVISORS INC has disclosed XRAY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is HEARTLAND ADVISORS INC's current position in XRAY?
As of Q3 2026, HEARTLAND ADVISORS INC holds 1.59M shares of XRAY (DENTSPLY SIRONA INC), valued at $14.10M, representing 0.68% of its reported portfolio and ranking #38.
Has HEARTLAND ADVISORS INC been buying or selling XRAY?
In the latest 13F filing (Q3 2026), HEARTLAND ADVISORS INC increased its position in XRAY. The position peaked in Q2 2025 at 1.53M shares.
Which other funds hold XRAY?
Other major institutional holders of XRAY include ARIEL INVESTMENTS, LLC, Southpoint Capital Advisors LP, among 12 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.